APA (7th ed.) Citation

Agnelli, G., Hoffmann, U., Hainaut, P., Gaine, S., Ay, C., Coppens, M., . . . Cohen, A. T. (2020). ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months. Thrombosis Research, 196, 297. https://doi.org/10.1016/j.thromres.2020.09.001

Chicago Style (17th ed.) Citation

Agnelli, Giancarlo, et al. "ETNA-VTE Europe: Benefits and Risks of Venous Thromboembolism Treatment Using Edoxaban in the First 3 months." Thrombosis Research 196 (2020): 297. https://doi.org/10.1016/j.thromres.2020.09.001.

MLA (9th ed.) Citation

Agnelli, Giancarlo, et al. "ETNA-VTE Europe: Benefits and Risks of Venous Thromboembolism Treatment Using Edoxaban in the First 3 months." Thrombosis Research, vol. 196, 2020, p. 297, https://doi.org/10.1016/j.thromres.2020.09.001.